Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Neuro-Oncology

Disease Sites: Neuro-Oncology

Phase: II

Investigator: Mohler, Alexander

NCTID: NCT05425004

Protocol No: VICC-ITNEU23261

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms

Disease Sites: Not Available

Phase: I

Investigator: Kishtagari, Ashwin

NCTID: NCT06313593

Protocol No: VICC-DTHEM24055P

A Phase I, Open Label Single-Arm Two-part Study to Investigate Safety, Pharmacokinetics, and Preliminary Efficacy of Pan-RAF/MEK Glue NST-628 Oral Tablets in Subject With Solid Tumors Harboring Genetic Alterations in the MAPK Pathway and With Other Solid Tumors

Disease Sites: Not Available

Phase: I

Investigator: Berlin, Jordan

NCTID: NCT06326411

Protocol No: VICC-DTPHI23579

Phase Ib Study of Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Multiple Cancer Types

Disease Sites: Leukemia, Myelodysplastic Syndrome, Phase I

Phase: I

Investigator: Ball, Somedeb

NCTID: NCT06399640

Protocol No: VICC-VCHEM23008P

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form